➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Moodys
Baxter
Colorcon
Harvard Business School

Last Updated: September 17, 2021

DrugPatentWatch Database Preview

Patent: 10,124,038

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,124,038
Title:Modulators of syndecan-2 and uses thereof
Abstract: Modulators of syndecan-2, such as an antibody to syndecan-2 that cross-links syndecan-2 on the cell surface or a syndecan-2 polypeptide that interferes with syndecan-2 receptor binding, is used to regulate a Th17 mediated disease such as an autoimmune disease, fibrosis or cancer.
Inventor(s): Elliman; Stephen J. (Galway, IE), Barkley; Laura Rose (Galway, IE), Kavanaugh; Jack (Los Angeles, CA)
Assignee: ORBSEN THERAPEUTICS LIMITED (Galway, IE)
Application Number:15/074,681
Patent Claims:see list of patent claims

Details for Patent 10,124,038

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX Orphan search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14 ⤷  Try it Free ORBSEN THERAPEUTICS LIMITED (Galway, IE) 2035-03-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,124,038

Country Patent Number Estimated Expiration
European Patent Office 3271396 ⤷  Try it Free
Japan 2018510879 ⤷  Try it Free
Japan 2021098708 ⤷  Try it Free
United States of America 2016271211 ⤷  Try it Free
United States of America 2019262421 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 2016150884 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Merck
Moodys
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.